Genentech Drug Shows Effect on a 2nd Cancer
Article Abstract:
Share of Genetech Inc. rose on the news that compared with a placebo, its cancer medication Avastin prolonged the lives of patients with advanced lung cancer.
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
Product information, Science & research, Securities issued, listed, Research, Securities, Dosage and administration, Company securities, Avastin (Medication)
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
2 Engines of Biotech on a Collision Course
Article Abstract:
Amgen Inc. and Genentech Inc. head in the same direction with their research and the line between the pharmaceutical and biotechnology industies in blurred.
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Sales, profits & dividends, Pharmaceutical preparations, Evaluation, Influence, Investments, Comparative analysis, Company sales and earnings, Corporate culture, Company earnings/profit, Amgen Inc., AMGN
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Clinical Trial Of Growth Drug Shows Promise
Article Abstract:
Using technology and patents bought from Genentech Inc., Tercica Inc. develops a growth drug for short children.
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Patents & copyrights, Drug therapy, Intellectual property, Growth disorders, Tercica Inc.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Product development, Biological products industry, Genentech Inc., DNA, Pharmaceutical industry
Similar abstracts:
- Abstracts: Media is a paper tiger. Collision course
- Abstracts: Peace with a price. Iraqification: a losing strategy
- Abstracts: The not-so-secret ace of spies. Detention deficit disorder
- Abstracts: Preparing to Go Extra Rounds, Candidates Set Their Priorities
- Abstracts: After 25 Years, Show's Last Season of Emotion-Laden Interviews. part 2 NBC Universal And Paxson: An Odd Dance To a Divorce
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.